corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 18 of 206 pages ‹ First  < 16 17 18 19 20 >  Last ›

HSL17606
Huckman M
The Funny Business Of Selling Drugs
CNBC Blog: Pharma's Market 2010 Apr 12
http://www.cnbc.com/id/36425501/The_Funny_Business_Of_Selling_Drugs

HSL17607
Three major pharmaceutical companies found in breach of ABPI code of practice
PJ Online 2010 Apr 12
http://www.pjonline.com/news/three_major_pharmaceutical_companies_found_in_breach_of_abpi_code_of_practice

HSL17608
Goozner M
Bad Medicine: The Real Cost of a Dangerous Drug
The Fiscal Times 2010 Apr 12
http://www.thefiscaltimes.com/Issues/Health-Care/2010/04/12/bad-medicine-the-real-cost-of-a-dangerous-drug.aspx

HSL17609
Bakalar N
Study Sees a Slant in Articles on Drug
The New York Times 2010 Apr 12
http://www.nytimes.com/2010/04/13/health/13diab.html

HSL17610
Richwine L
US groups urge drug safety steps with industry fees
Reuters 2010 Apr 12
http://www.reuters.com/article/idUSN0913305520100412

HSL17642
Shankar R
MCI intensifies demand for amending D&C Act to make pharma companies punishable for bribing doctors
PharmaBiz.com 2010 Apr 12
http://www.essentialdrugs.org/edrug/archive/201004/msg00019.php

HSL17644
Smith P
Homeopath defies retraction order
Pharmacy News 2010 Apr 12
http://www.pharmacynews.com.au/article/homeopath-defies-retraction-order/515209.aspx

HSL17754
Wang N, Lipworth WL, Ritchie JE, Williams KM, Day RO.
Eliciting views of Australian pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines.
Intern Med J 2010 Apr 12;
http://www3.interscience.wiley.com/journal/123349392/abstract

HSL17579
Strengthening the credibility of clinical research
The Lancet 2010 Apr 10;375:(9722):1225
http://www.thelancet.com/journals/lancet/article/PIIS0140673610605235/fulltext

HSL17587
England's libel laws: silencing scientific debate
The Lancet 2010 Apr 10;375:(9722):1226
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)60525-9/fulltext

HSL17588
Scull A
A psychiatric revolution
The Lancet 2010 Apr 10;375:(9722):1246 - 1247
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)60532-6/fulltext

HSL17575
Schofield H
Legal fight over Plumpy'nut, the hunger wonder-product
BBC News 2010 Apr 8
http://news.bbc.co.uk/2/hi/europe/8610427.stm

HSL17580
Fauber J
69 Wisconsin doctors show up on Pfizer payroll
The Journal Sentinel 2010 Apr 8
http://www.jsonline.com/features/health/90323677.html

HSL17581
Séguin R
Quebec pursues drug companies over prices
The Globe and Mail 2010 Apr 8
http://www.theglobeandmail.com/news/national/quebec-pursues-drug-companies-over-prices/article1528438/

HSL17582
Mack J
An Analysis of DDMAC Warning Letters Regarding Risk Information in Broadcast Drug Ads
Pharma Marketing Blog 2010 Apr 8
http://pharmamkting.blogspot.com/2010/04/analysis-of-ddmac-warning-letters.html

HSL17595
Godlee F
Vested interests
BMJ 2010 Apr 8;340:
http://www.bmj.com/cgi/content/extract/340/apr08_2/c1922

HSL17596
Arnold M
Third-parties may be key to social media cred, says survey
Medical Marketing & Media 2010 Apr 8
http://www.mmm-online.com/third-parties-may-be-key-to-social-media-cred-says-survey/article/167621/

HSL17645
Cannane S
Homeopathy websites ignore retraction orders
Lateline : ABC 2010 Apr 8
http://www.abc.net.au/lateline/content/2010/s2867990.htm

HSL17554
Taylor L
QALYs are 'an industry trick,' says German health chief
Pharma Times 2010 Apr 7
http://www.pharmatimes.com/WorldNews/article.aspx?id=17664

HSL17563
Moynihan R
Rosiglitazone, marketing, and medical science
BMJ 2010 Apr 7;340:
http://www.bmj.com/cgi/content/extract/340/apr07_2/c1848

HSL17564
Moynihan R
American Council on Science and Health
BMJ 2010 Apr 7;340:
http://www.bmj.com/cgi/content/extract/340/apr07_2/c1819

HSL17565
Delamothe T
Data sharing: let the sunshine in
BMJ 2010 Apr 7;340:
http://www.bmj.com/cgi/content/extract/340/apr07_2/c1896

HSL17566
Grayling AC
We should reform libel laws in light of Singh victory
BMJ 2010 Apr 7;340:
http://www.bmj.com/cgi/content/extract/340/apr07_2/c1910

HSL17568
Comer B
FDA says competing biologic ads both misled
Medical Marketing & Media 2010 Apr 7
http://www.mmm-online.com/fda-says-competing-biologic-ads-both-misled/article/167545/

HSL17576
Kopf Hirsh J
Overactive bladder? You might think so after seeing Toviaz ad
Consumer Reports: Health Blog 2010 Apr 7
http://blogs.consumerreports.org/health/2010/04/adwatch-overactive-bladder-you-might-think-so-after-seeing-toviaz-ad-treating-overactive-bladder.html

HSL17597
Perrone M
FDA cracking down on fat-melting injections
The Washington Post 2010 Apr 7
http://www.washingtonpost.com/wp-dyn/content/article/2010/04/07/AR2010040702497.html

HSL17598
Heavey S
UPDATE 2-U.S. FDA warns Gilead, Biogen over drug promotions
Reuters 2010 Apr 7
http://www.reuters.com/article/idUSN0711570520100407

HSL17601
George J
As FDA debates social media rules, pharma isn’t waiting
Philadelphia Business Journal 2010 Apr 7
http://philadelphia.bizjournals.com/philadelphia/stories/2010/04/05/focus1.html

HSL17638
Drug Marketing Moves to Digital: How Pharmaceutical Companies Pitch Consumers Online
Center for Digital Democracy 2010 Apr 7
http://www.democraticmedia.org/drup-marketing-moves-to-digital

HSL17641
Sayre A
La. gets $20 million in Eli Lilly drug settlement
Yahoo Finance 2010 Apr 7
http://www.ibj.com/louisiana-gets-20m-in-lilly-drug-settlement/PARAMS/article/19159

HSL17551
Curran J
Drug company expenditures down in Vermont
Business Week 2010 Apr 6
http://www.businessweek.com/ap/financialnews/D9ETIH0O1.htm

HSL17567
Leonhardt D
In Medicine, the Power of No
The New York Times 2010 Apr 6
http://www.nytimes.com/2010/04/07/business/economy/07leonhardt.html

HSL17570
Unnikrishnan CH
Pfizer, Novartis and Eli Lilly got bulk of contentious patents
Livemint.com 2010 Apr 6
http://www.livemint.com/2010/04/06214301/Pfizer-Novartis-and-Eli-Lilly.html

HSL17552
Silverman E
Allan Coukell On Payments To Doctors & Disclosure
Pharmalot 2010 Apr 5
http://www.pharmalot.com/2010/04/allan-coukell-on-payments-to-doctors-disclosure/

HSL17553
Silverman E
Who Really Suffers If Pfizer Is Too Big To Fail?
Pharmalot 2010 Apr 5
http://www.pharmalot.com/2010/04/who-really-suffers-if-pfizer-is-too-big-to-fail/

HSL17599
Drug controller seeks details from Dr Reddy's
The Hindu Business Line 2010 Apr 5
http://www.thehindubusinessline.com/todays-paper/tp-corporate/article988361.ece

HSL17600
Thomaselli R
Drug Report: Consumers Rate Rx Remedies Online
The Advertising Age 2010 Apr 5
http://adage.com/digital/article?article_id=143128

HSL17668
Barkley D
Schooling doctors
PM Live 2010 Apr 5
http://www.pmlive.com/find_an_article/allarticles/categories/pr_and_med_ed/2010/april/features/schooling_doctors

HSL17584
Brody H
CNN: Pfizer Too Big to Prosecute; Shadow Company Takes the Hit
Hooked: Ethics, Medicine and Pharma 2010 Apr 4
http://brodyhooked.blogspot.com/2010/04/cnn-pfizer-too-big-to-prosecute-shadow.html

HSL17555
Guilliatt R
Scientist `deceived' by drugs giant
The Australian 2010 Apr 3
http://www.theaustralian.com.au/news/health-science/scientist-deceived-by-drugs-giant/story-e6frg8y6-1225849066072

HSL17556
Silverman E
Is The FDA Proposal For DTC Ads Too Vague?
Pharmalot 2010 Apr 2
http://www.pharmalot.com/2010/04/is-the-fda-proposal-for-dtc-ads-too-vague/

HSL17562
Griffin D, Segal A
Feds found Pfizer too big to nail
CNN 2010 Apr 2
http://edition.cnn.com/2010/HEALTH/04/02/pfizer.bextra/index.html

HSL17569
Iskowitz M
FDA proposes standard for print, broadcast drug ads
Medical Marketing & Media 2010 Apr 2
http://www.mmm-online.com/fda-proposes-standard-for-print-broadcast-drug-ads/article/167222/

HSL17571
Edwards J
Memo to the DOJ: 'Pfizer Isn't Too Big to Nail' -- Don't Let Management Off the Hook
BNet 2010 Apr 2
http://industry.bnet.com/pharma/10007526/how-prosecutors-who-say-pfizer-is-too-big-to-nail-are-letting-management-off-the-hook/

HSL17577
Kinnard M
APNewsBreak: SC to get $12.7 million under deal with Pfizer Inc. over disputed sales tactics
The Star Tribune 2010 Apr 2
http://www.boston.com/business/healthcare/articles/2010/04/02/apnewsbreak_sc_reaches_127m_deal_with_pfizer/

HSL17583
Carlat D
Trickle Down Deception: Restaurants and the Pharmaceutical Industry
The Carlat Psychiatry Blog 2010 Apr 2
http://carlatpsychiatry.blogspot.com/2010/04/trickle-down-deception-restaurants-and.html

HSL17557
Taylor L
Drugmakers slam German price moves
Pharma Times 2010 Apr 1
http://www.pharmatimes.com/WorldNews/article.aspx?id=17645

HSL17558
Dorschner J
University of Miami database to reveal payments to doctors
The Miami Herald 2010 Apr 1
http://www.miamiherald.com/2010/04/01/1557671/university-of-miami-database-to.html

HSL17572
Edwards J
The Big Pharma Transparency Report Card: Congratulations, Merck. Lilly? Needs Improvement
BNet 2010 Apr 1
http://industry.bnet.com/pharma/10007516/the-big-pharma-transparency-report-card-congratulations-merck-lilly-could-do-better/

HSL17612
Mazur S
The Peer Review 'Fig Leaf': Vera Hassner Sharav
Scoop Independent News 2010 Apr 1
http://www.scoop.co.nz/stories/HL1004/S00011.htm

HSL17496
Ryan C, Walter G, Robertson M.
College activities and the ethics of advertising.
Australas Psychiatry 2010 Apr;18:(2):101-5
http://informahealthcare.com/doi/abs/10.3109/10398561003665577

HSL17497
Jurd S.
The marketing of pharmaceutical agents: friend or foe?
Australas Psychiatry 2010 Apr;18:(2):97-100
http://informahealthcare.com/doi/abs/10.3109/10398561003665460

HSL17522
Cassels A
Big Pharma’s solution for our health woes: more and more pills for the elderly
Common Ground 2010 Apr
http://www.commonground.ca/iss/225/cg225_cassels.shtml

HSL17535
Boumil SJ 3rd, Nariani A, Boumil MM, Berman HA.
Whistleblowing in the pharmaceutical industry in the United States, England, Canada, and Australia.
J Public Health Policy 2010 Apr;31:(1):17-29
http://www.palgrave-journals.com/jphp/journal/v31/n1/abs/jphp200951a.html

HSL17536
Fullerton CA, Busch AB, Frank RG.
The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion.
Med Care 2010 Apr;48:(4):372-9
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=L8wNm6JD8f9P2GBlStd06rl5lwJVn4wSqVV3vdN2snGG7X1jD1c3!-911972257!181195629!8091!-1?issn=0025-7079&volume=48&issue=4&spage=372

HSL17750
Menghaney L.
Patent dispute: Delhi High Court gives a boost to access to affordable medicines.
Indian J Med Ethics 2010 Apr-Jun;7:(2):97-100
http://www.ncbi.nlm.nih.gov/pubmed/20432882

HSL17794
Carmody D, Mansfield PR
What do medical students think about pharmaceutical promotion?
Australian Medical Student Journal 2010 Apr;1:(1):54-7
http://www.amsj.org/archives/300

HSL17952
Madden JM, Meza E, Ewen M, Laing RO, Stephens P, Ross-Degnan D.
Measuring medicine prices in Peru: validation of key aspects of WHO/HAI survey methodology.
Rev Panam Salud Publica 2010 Apr;27:(4):291-9
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000400008&lng=en&nrm=iso&tlng=en

HSL18281
[No authors listed].
A look back at 2009: one step forward, two steps back.
Prescrire Int 2010 Apr;19:(106):89-94
http://www.ncbi.nlm.nih.gov/pubmed/20568499

HSL18513
Whayne TF Jr.
[Problems with statins and the marketing of these medications].
Rev Med Chil 2010 Apr;138:(4):511-4
http://scielo.php/?script=sci_arttext&pid=S0034-98872010000400018&tlng=en&lng=en&nrm=iso

HSL17573
Edwards J
J&J Writes a New Chapter of the Pharma Book, 'Why Drug Prices Are High'
BNet 2010 Mar 31
http://industry.bnet.com/pharma/10007503/jj-writes-new-chapter-of-book-titled-why-prices-are-high/

HSL17574
Edwards J
Fines Haven't Stopped Drug Company Lawbreaking -- Maybe Jail Time for Executives Would
BNet 2010 Mar 31
http://industry.bnet.com/pharma/10007330/fines-havent-stopped-drug-company-lawbreaking-jailtime-for-executives-might/

HSL17614
Berkrot B, Pierson R, Krauskopf L
Pfizer paid $35 mln to doctors over 6 months
Reuters 2010 Mar 31
http://www.reuters.com/article/idUSTRE62U4UM20100331

HSL17615
Taylor L
EU govts warned over 'enforced, unpredicted' Rx price cuts
Pharma Times 2010 Mar 31
http://www.pharmatimes.com/WorldNews/article.aspx?id=17639

HSL17616
Spence D
Politics of conflict: doctors, like MPs, should declare their interests
BMJ 2010 Mar 31;340:
http://www.bmj.com/cgi/content/extract/340/mar31_2/c1780

HSL17603
Garattini S, Bertele V
Europe’s opportunity to open up drug regulation
BMJ 2010 Mar 30;340:
http://www.bmj.com/cgi/content/extract/340/mar30_2/c1578

HSL17544
Tolve A
Why Pharma needs a New Commercial Model
Eyeforpharma.com 2010 Mar 30
http://social.eyeforpharma.com/story/why-pharma-needs-new-commercial-model

HSL17560
Lam T
PM orders inquiry into US drug-company kickbacks for doctors
Saigon GP Daily 2010 Mar 30
http://www.saigon-gpdaily.com.vn/Health/2010/3/80663/

HSL17613
Wokasch M
Healthcare reform driven marketing challenges to 'stimulating product interest'
Pharma Reform 2010 Mar 30
http://www.pharmareform.com/2010/03/30/healthcare-reform-driven-marketing-challenges-to-stimulating-product-interest/

HSL17618
Wilson D
Risks Seen in Cholesterol Drug Use in Healthy People
The New York Times 2010 Mar 30
http://www.nytimes.com/2010/03/31/business/31statins.html

HSL17504
Silverman E
A Sanofi Drug, A Web Site & Lack Of Disclosure
Pharmalot 2010 Mar 29
http://www.pharmalot.com/2010/03/a-sanofi-heart-drug-a-web-site-lack-of-disclosure/

HSL17344
O’Hanlon S
My year without drug reps
BMJ 2010 Mar 29;340:c1102
http://www.bmj.com/cgi/content/extract/340/mar03_2/c1102

HSL17506
Mack J
MicroBlogging About 'Newsworthy' Events: Should Pharma Follow FDA's Lead?
Pharma Marketing Blog 2010 Mar 29
http://pharmamkting.blogspot.com/2010/03/microblogging-about-newsworthy-events.html

HSL17521
Cegedim Strategic Data (CSD) Releases Global Pharmaceutical Marketing Investment Figures for 12 Months Ending December 2009
Market Watch 2010 Mar 29
http://www.marketwatch.com/story/cegedim-strategic-data-csd-releases-global-pharmaceutical-marketing-investment-figures-for-12-months-ending-december-2009-2010-03-29

HSL17534
Wokasch M
Healthcare Reform Impact on Pharmaceutical Marketing
Pharma Reform 2010 Mar 29
http://www.pharmareform.com/2010/03/29/healthcare-reform-impact-on-pharmaceutical-marketing/

HSL17547
Macrae F
Pill-popper nation: Prescriptions soar as we pick up more than 16 EACH every year
The Daily Mail 2010 Mar 29
http://www.dailymail.co.uk/news/article-1261436/A-nation-pill-poppers-Prescriptions-soar-pick-16-EACH-year.html

HSL17669
Russia passes Pharmaceutical Bill
PM Live 2010 Mar 29
http://www.pmlive.com/find_an_article/allarticles/categories/General/2010/march/news/russia_passes_pharmaceutical_bill

HSL17670
Rowley M
Building a good defence
PM Live 2010 Mar 29
http://www.pmlive.com/find_an_article/allarticles/categories/General/2010/march/featureds/building_a_good_defence

HSL17752
O'Hanlon S.
My year without drug reps.
BMJ 2010 Mar 29;340:c1102:
http://www.bmj.com/cgi/content/full/340/mar29_2/c1102?view=long&pmid=20351076

HSL17487
W5 Investigates: Pills, Patients and Profits
CTV W5 2010 Mar 27
http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20100326/w5_pills_100326/20100327

HSL17509
Cleaver H
Rösler infuriates pharma industry with plan to cut drugs costs
The Local 2010 Mar 27
http://www.thelocal.de/money/20100327-26165.html

HSL17490
Wang SS
Let the Sun Shine In: Payments to Docs from Companies to be Disclosed
The Wall Street Journal 2010 Mar 26
http://blogs.wsj.com/health/2010/03/26/let-the-sun-shine-in-payments-to-docs-from-companies-to-be-disclosed/

HSL17491
Edwards J
This Oral-Sex Cancer Scare Brought to You by GlaxoSmithKline
BNet 2010 Mar 26
http://industry.bnet.com/pharma/10007425/this-oral-sex-cancer-scare-is-brought-to-you-by-glaxosmithkline/

HSL17492
Edwards J
Did Sanofi Sponsorship Push the Legal Envelope on Its Disappointing New Heart Drug?
BNet 2010 Mar 26
http://industry.bnet.com/pharma/10007414/sanofi-pushes-the-legal-envelope-on-its-disappointing-new-heart-drug/

HSL17499
Carlat D
The Physician Sunshine Act: Time for Hired Guns to Scatter
The Carlat Psychiatry Blog 2010 Mar 26
http://carlatpsychiatry.blogspot.com/2010/03/physician-sunshine-act-time-for-hired.html

HSL17594
Kim K, Seong Park J
Message framing and the effectiveness of DTC advertising: The moderating role of subjective product knowledge
Journal of Medical Marketing 2010 Mar 26;10:(2):165–176
http://www.palgrave-journals.com/jmm/journal/v10/n2/abs/jmm20104a.html

HSL17505
Whelan D
Little Pricey Pill
Forbes 2010 Mar 25
http://www.forbes.com/forbes/2010/0412/opinions-healthcare-nexium-hmo-prescriptions-heads-up.html

HSL17485
Iskowitz M
In protecting market research, federal exclusion may not always apply
Medical Marketing & Media 2010 Mar 25
http://www.mmm-online.com/in-protecting-market-research-federal-exclusion-may-not-always-apply/article/166563/?DCMP=EMC-

HSL17486
Nussbaum A, Tirrell M, Wechsler P
Health Law Surprise Is Page 1,617 Demanding Which Drugs Work
Bloomberg News 2010 Mar 25
http://www.bloomberg.com/apps/news?pid=20601202&sid=aWaqUjSAjgAg

HSL17488
US jury's Neurontin ruling to cost Pfizer $141 mln
Reuters 2010 Mar 25
http://www.reuters.com/article/idUSN259778920100325

HSL17500
Brody H
More on Strict Measures Proposed in India
Hooked: Ethics, Medicine and Pharma 2010 Mar 25
http://brodyhooked.blogspot.com/2010/03/more-on-strict-measures-proposed-in.html

HSL17617
Arnold M
Europe edges US in social media for health info, says study
Medical Marketing & Media 2010 Mar 25
http://www.mmm-online.com/europe-edges-us-in-social-media-for-health-info-says-study/article/166461/

HSL17431
Insel TR
Psychiatrists' Relationships With Pharmaceutical Companies: Part of the Problem or Part of the Solution?
JAMA 2010 Mar 24;303:(12):1192-1193
http://jama.ama-assn.org/cgi/content/short/303/12/1192

HSL17434
Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH
Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects
JAMA 2010 Mar 24;303:(12):1180-1187
http://jama.ama-assn.org/cgi/content/abstract/303/12/1180

HSL17435
DeAngelis CD, Fontanarosa PB
Ensuring Integrity in Industry-Sponsored Research
JAMA 2010 Mar 24;303:(12):1196-1198
http://jama.ama-assn.org/cgi/content/extract/303/12/1196

HSL17437
Nissen SE
Setting the RECORD Straight
JAMA 2010 Mar 24;303:(12):1194-1195
http://jama.ama-assn.org/cgi/content/extract/303/12/1194

HSL17493
Edwards J
Medical Journals: Still Too Lazy to ID Pharma-Funded Research
BNet 2010 Mar 24
http://industry.bnet.com/pharma/10007359/in-the-lazy-world-of-medical-journals-pharma-funding-often-goes-unnoticed/

HSL17542
Consumer watchdog air concerns over Sigma reward program
International Business Times 2010 Mar 24
http://ibtimes.com.au/articles/20100324/consumer-watchdog-air-concerns-over-sigma-reward-program.htm

HSL17543
Lekakis G
Watch on chemist reward scheme
The Herald Sun 2010 Mar 24
http://www.heraldsun.com.au/business/watch-on-chemist-reward-scheme/story-e6frfh4f-1225844496833

HSL17578
Citrome L
Citability of Original Research and Reviews in Journals and Their Sponsored Supplements
PLoS One 2010 Mar 24;
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0009876

Page 18 of 206 pages ‹ First  < 16 17 18 19 20 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







What these howls of outrage and hurt amount to is that the medical profession is distressed to find its high opinion of itself not shared by writers of [prescription] drug advertising. It would be a great step forward if doctors stopped bemoaning this attack on their professional maturity and began recognizing how thoroughly justified it is.
- Pierre R. Garai (advertising executive) 1963